|
Session 1 |
|
|
15:30-17:00 |
Opening Session |
|
|
|
Why is fertility preservation not yet available to all suitable survivors?
Gedis Grudzinskas, UK |
|
Cryotechnology – What is next?
Amir Arav, Israel |
|
Fertility preservation - What options do we really have?
Pasquale Patrizio, USA |
|
|
|
17:00-17:30 |
Coffee Break |
|
|
|
Session 1a |
|
|
17:30-18:30 |
Opening Session (Continued) |
|
|
|
Science fiction or future reality? Producing gametes from stem cells and somatic cells
Gerald Schatten, USA |
|
How to select the patient for fertility preservation?
Uzi Beller, Israel |
|
18:30-20:00 |
Welcome Reception |
|
|
|
Friday, March 22, 2013 |
|
Session 2 |
|
|
08:30-10:00 |
The Techniques Available Today for Cryopreservation? |
|
|
|
The possibility to vitrify egg, embryo and creating the suitable bank
Ana Cobo, Spain |
|
Fresh and frozen ovary transplant results
Sherman Silber, USA |
|
Can we transplant ovarian tissue from cancer patients?
Dror Meirow, Israel |
|
Pregnancy from frozen slices of ovary
Jacques Donnez, Belgium |
|
|
|
10:00-10:30 |
Coffee Break |
|
|
|
|
|
Session 3 |
|
|
|
10:30-12:30 |
Evaluating and Protecting Ovarian Reserve |
|
|
|
|
|
Evaluation of Ovarian Reserve: Application to clinical practice
Talia Eldar-Geva, Israel |
|
|
Stimulation for egg retrieval (IVF) in cancer patients before starting treatment
Nicole Noyes, USA |
|
|
Function of ovaries following transposition and pelvic irradiation
Nicholas Reed, Scotland |
|
|
The role of IVM in cancer patients
Evelyn Tefler, UK |
|
|
12:30-13:30 |
Lunch Break |
|
|
|
|
|
Session 4 |
|
|
|
13:30-15:00 |
F.P. in Endometrial Cancer and Ovarian Cancer |
|
|
|
|
|
Outcome of fertility preserving therapies for endometrial cancer
Walter Gotlieb, Canada |
|
|
Epithlial ovarian cancer
Nicoletta Colombo, Italy |
|
|
Borderline tumor and none epithelial cancer
Philippe Morice, France |
|
|
Case presentation
Uzi Beller, Israel |
|
|
|
|
|
15:00-15:30 |
Coffee Break |
|
|
|
|
|
Session 5 |
|
|
|
15:30-17:30 |
F.P. in Breast Cancer |
|
|
|
|
|
Epidemiologic and prognostic consideration
TBA |
|
|
Diminished ovarian reserve in breast cancer patients with BRACA1 mutation
Norbert Gleicher, USA |
|
|
F.P for BRCA carriers
Rachel Michaelson-Cohen, Israel |
|
|
An ounce of prevention is worth a pound of cure
Zeev Blumenfeld, Israel |
|
|
|
|
|
Saturday, March 23, 2013 |
|
|
Session 6 |
|
|
|
08:30-10:00 |
HPV Infection and Fertility Preservation |
|
|
|
|
|
Vaccination
Lutz Gissmann, Germany |
|
|
Tissue sparing surgery
Achim Schneider, Germany |
|
|
Photodynamic therapy
Peter Hillemanns, Germany |
|
|
Therapeutic vaccination
Gemma Kenter, The Netherlands |
|
|
|
|
|
10:00-10:30 |
Coffee Break |
|
|
|
|
|
Session 7 |
|
|
|
10:30-11:30 |
Cervix Cancer: Principles, Patient Selection, Surgical Techniques and Pregnancy Results Outcome |
|
|
|
|
|
Radical Vaginal Trachelectomy
Achim Schneider, Germany |
|
|
Radical Abdominal TrachelectomyNadeem Abu-Rustum, USA |
|
|
Radical Abdominal Trachelectomy for stage 1B2
Ungar Laszlo, Hungary |
|
|
Case presentation
Uzi Beller, Israel |
|